Bacteria profile and antibiogram of the bacteria isolated from the exposed pulp of dog canine teeth

Twenty-seven microbiological samples were taken from root canals (RC) of the canine teeth of 20 dogs where the pulps were non-vital and exposed due to complicated crown fractures. These pulps were cultured for aerobic/anaerobic bacteria. Antimicrobial susceptibility of isolates was determined using...

Full description

Saved in:
Bibliographic Details
Published in:Veterinary record 2018-07, Vol.183 (3), p.97-97
Main Authors: Almansa Ruiz, José Carlos, Jonker, Annelize, Bosman, Anna-Mari, Steenkamp, Gerhard
Format: Article
Language:English
Subjects:
Animals
Anti-Bacterial Agents - pharmacology
Antibiotics
Antimicrobial agents
Bacteria
Bacteria - drug effects
Bacteria - isolation & purification
Cuspid - microbiology
Dentistry
Dogs
Female
Infections
Laboratories
Male
Microbial Sensitivity Tests - veterinary
Microorganisms
non‐vital pulp
root canal
Specialty products
Success
Systematic review
Teeth
Tropical diseases
Veterinary medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Twenty-seven microbiological samples were taken from root canals (RC) of the canine teeth of 20 dogs where the pulps were non-vital and exposed due to complicated crown fractures. These pulps were cultured for aerobic/anaerobic bacteria. Antimicrobial susceptibility of isolates was determined using the Kirby-Bauer diffusion test. A total of 49 cultivable isolates, belonging to 27 different microbial species and 18 different genera, were recovered from the 27 RCs sampled. Twenty (40.81 per cent) of the cultivable isolates were Gram positive while 29 (59.19 per cent) were Gram negative. Facultative anaerobes were the most common bacteria (77.56 per cent). Aerobic isolates represented 18.36 per cent, and strict anaerobes 4.08 per cent. The antimicrobials with the highest in vitro efficacy were gentamicin (100 per cent) and enrofloxacin (93.32 per cent).
ISSN:0042-4900
2042-7670
DOI:10.1136/vr.104540